phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Phase 1 BAFF CAR T clinical trial for patients with relapsed and refractory multiple myeloma underway at UH Seidman Cancer Center

University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was completed, the team has shown that it's feasible to manufacture BAFF CAR T-cells for human subjects.

August 15, 2024


August 29 2024

August 28 2024

August 27 2024

August 26 2024

August 25 2024

August 24 2024

August 23 2024

August 22 2024

August 21 2024

August 20 2024

August 19 2024

August 18 2024

August 17 2024

August 16 2024

August 15 2024

Angell Street Psychiatry
Copyright 2024 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy